{"id":"tp-48211","type":"article-newspaper","title":"Arvinas Starts ARV-6723 Dosing, Reports $558.9 Million in Liquidity","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/48211","datePublished":"2026-11-04T04:11:04.000Z","dateModified":"2026-11-04T04:11:04.000Z","language":"en","abstract":"Arvinas expects initial monotherapy data for ARV-6723 in the second half of 2027, while ARV-393 data are planned for a December hematology meeting.","section":"Business","references":[]}